William Blair Investment Management
LFCR icon

William Blair Investment Management’s Lifecore Biomedical LFCR Stock Holding History

William Blair Investment Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-401,638
Closed -$4.46M – 448
2021
Q4 		$4.46M Sell
401,638
-23,969
-6% -$233K 0.01% 357
2021
Q3 		$3.92M Buy
425,607
+423,272
+18,127% +$4.61M 0.01% 372
2021
Q2 		$26K Buy
+2,335
New +$26.9K ﹤0.01% 462

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management's LFCR Position: Q1 2022 in Review

William Blair Investment Management sold out of Lifecore Biomedical (LFCR) in Q1 2022, closing a stake of 401,638 shares — an estimated $4.46M sold.

William Blair Investment Management first reported a position in LFCR in Q2 2021 and held it in 3 quarters. The position peaked at $4.46M in Q4 2021. 97 funds tracked by Wall St. Rank hold LFCR as of Q1 2022.

  • William Blair Investment Management reported no remaining Lifecore Biomedical position as of Q1 2022 after selling out during the quarter.
  • William Blair Investment Management sold 401,638 Lifecore Biomedical shares in Q1 2022, an estimated $4.46M.
  • William Blair Investment Management first reported a position in Lifecore Biomedical in Q2 2021 and held it in 3 quarters.
  • William Blair Investment Management's Lifecore Biomedical position peaked at $4.46M in Q4 2021.
  • 97 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2022.

Based on William Blair Investment Management's 13F filing for Q1 2022, filed 11 May 2022.